2.4.0.84130 - Disclosure - Segment Information (Details)truefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$D2013Q2http://www.sec.gov/CIK0001344154duration2013-04-01T00:00:002013-06-30T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$D2012Q2http://www.sec.gov/CIK0001344154duration2012-04-01T00:00:002012-06-30T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDfalsefalse$D2013Q2YTDhttp://www.sec.gov/CIK0001344154duration2013-01-01T00:00:002013-06-30T00:00:00ItemStandardhttp://www.envisionhealthcare.net/20130630itemevh0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$4false USDfalsefalse$D2012Q2YTDhttp://www.sec.gov/CIK0001344154duration2012-01-01T00:00:002012-06-30T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 1us-gaap_SegmentReportingAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Segment Information2false 2us-gaap_NumberOfOperatingSegmentsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse22falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:integerItemTypeintegerNumber of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.No definition available.false256Number of separately managed business units3true 3us-gaap_SegmentReportingInformationLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Segment Information4false 4evh_RevenueHealthCareOrganizationevh_falsecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse899255000899255USD$falsetruefalse2truefalsefalse801098000801098USD$falsetruefalse3truefalsefalse17875790001787579USD$falsetruefalse4truefalsefalse16073920001607392USD$falsetruefalsexbrli:monetaryItemTypemonetaryThe sum of revenues recognized during the period by the entity from providing services to in-patients, outpatients, residents in facilities owned or operated by the entity, from insurance premiums, or from goods provided or services performed. For financial reporting purposes, revenue is reflected net of provisions for contractual allowances (the amount needed to reduce the entity's gross billing rates to agreed-upon rates in contracts with third-party payers) and provisions for uncompensated care (the amount needed to reduce revenue for services provided to patients without insurance or other third-party payer coverage).No definition available.false2Net revenue5false 4evh_IncomeLossBeforeInterestTaxDepreciationAndAmortizationNetevh_falsecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse105956000105956USD$falsefalsefalse2truefalsefalse9633200096332USD$falsefalsefalse3truefalsefalse206955000206955USD$falsefalsefalse4truefalsefalse187896000187896USD$falsefalsefalsexbrli:monetaryItemTypemonetaryRepresents income or loss from continuing operations excluding equity in earnings of unconsolidated subsidiary, income tax expense, loss on early debt extinguishment, interest and other (expense) income, realized (loss) gain on investments, interest expense, stock-based compensation, related party management fees, restructuring charges, and depreciation and amortization expense used by chief operating decision maker to assess performance, measure liquidity and make decisions.No definition available.false2Adjusted EBITDA6true 4evh_ReconciliationOfAdjustedEBITDAToNetIncomeAbstractevh_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Reconciliation of Adjusted EBITDA to Net Income7false 5evh_IncomeLossBeforeInterestTaxDepreciationAndAmortizationNetevh_falsecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse105956000105956USD$falsefalsefalse2truefalsefalse9633200096332USD$falsefalsefalse3truefalsefalse206955000206955USD$falsefalsefalse4truefalsefalse187896000187896USD$falsefalsefalsexbrli:monetaryItemTypemonetaryRepresents income or loss from continuing operations excluding equity in earnings of unconsolidated subsidiary, income tax expense, loss on early debt extinguishment, interest and other (expense) income, realized (loss) gain on investments, interest expense, stock-based compensation, related party management fees, restructuring charges, and depreciation and amortization expense used by chief operating decision maker to assess performance, measure liquidity and make decisions.No definition available.false2Adjusted EBITDA8false 5us-gaap_DepreciationAndAmortizationus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse-34622000-34622USD$falsefalsefalse2truefalsefalse-30762000-30762USD$falsefalsefalse3truefalsefalse-69377000-69377USD$falsefalsefalse4truefalsefalse-61252000-61252USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThe current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 5 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585 false2Depreciation and amortization expense9false 5us-gaap_RestructuringChargesus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse-3032000-3032USD$falsefalsefalse2truefalsefalse-2744000-2744USD$falsefalsefalse3truefalsefalse-3669000-3669USD$falsefalsefalse4truefalsefalse-8723000-8723USD$falsefalsefalsexbrli:monetaryItemTypemonetaryAmount charged against earnings in the period for incurred and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, excluding asset retirement obligations.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB TOPIC 5.P.4(b)) -URI http://asc.fasb.org/extlink&oid=6394695&loc=d3e140904-122747 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 5.P.3) -URI http://asc.fasb.org/extlink&oid=6394695&loc=d3e140864-122747 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 5 -Section P -Subsection 3, 4 false2Restructuring charges10false 5us-gaap_ShareBasedCompensationus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse-1062000-1062USD$falsefalsefalse2truefalsefalse-1062000-1062USD$falsefalsefalse3truefalsefalse-2124000-2124USD$falsefalsefalse4truefalsefalse-2124000-2124USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThe aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585 false2Equity-based compensation expense11false 5evh_ManagementFeeRelatedPartyevh_falsedebitdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse-1250000-1250USD$falsefalsefalse2truefalsefalse-1250000-1250USD$falsefalsefalse3truefalsefalse-2500000-2500USD$falsefalsefalse4truefalsefalse-2500000-2500USD$falsefalsefalsexbrli:monetaryItemTypemonetaryRepresents the amount of management fees for the period incurred from transactions with related parties.No definition available.false2Related party management fees12false 5us-gaap_InterestExpenseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse-38538000-38538USD$falsefalsefalse2truefalsefalse-41514000-41514USD$falsefalsefalse3truefalsefalse-78828000-78828USD$falsefalsefalse4truefalsefalse-84966000-84966USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThe cost of borrowed funds accounted for as interest that was charged against earnings during the period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 34 -Paragraph 21 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04.9) -URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 9 -Article 9 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher OTS -Name Federal Regulation (FR) -Number Title 12 -Section 563c.102 -Paragraph 9 -Chapter V -Subsection II -LegacyDoc This is a non-GAAP reference that was included in the 2009 taxonomy. It will be removed from future versions of this taxonomy. false2Interest expense13false 5us-gaap_GainLossOnSaleOfInvestmentsus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalsepositiveLabel1truefalsefalse105000105USD$falsefalsefalse2truefalsefalse6300063USD$falsefalsefalse3truefalsefalse118000118USD$falsefalsefalse4truefalsefalse361000361USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThe net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585 false2Realized gain on investments14false 5us-gaap_OtherNonoperatingIncomeExpenseus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse-249000-249USD$falsefalsefalse2truefalsefalse241000241USD$falsefalsefalse3truefalsefalse-12970000-12970USD$falsefalsefalse4truefalsefalse403000403USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThe net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 9 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.9) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 false2Interest and other (expense) income15false 5us-gaap_GainsLossesOnExtinguishmentOfDebtus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2truefalsefalse-5172000-5172USD$falsefalsefalse3truefalsefalse-122000-122USD$falsefalsefalse4truefalsefalse-5172000-5172USD$falsefalsefalsexbrli:monetaryItemTypemonetaryDifference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 50 -Section 40 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6850294&loc=d3e12317-112629 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 50 -Section 40 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6850294&loc=d3e12355-112629 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 26 -Paragraph 20, 21 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false2Loss on early debt extinguishment16false 5us-gaap_IncomeTaxExpenseBenefitus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse-10832000-10832USD$falsefalsefalse2truefalsefalse-6266000-6266USD$falsefalsefalse3truefalsefalse-17966000-17966USD$falsefalsefalse4truefalsefalse-10504000-10504USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThe sum of the current income tax expense or benefit and the deferred income tax expense or benefit pertaining to continuing operations.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(h)) -URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph h -Article 4 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Income Tax Expense (or Benefit) -URI http://asc.fasb.org/extlink&oid=6515339 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 9 -Subparagraph (a),(b) -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 109 -Paragraph 45 -Subparagraph a, b -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false2Income tax expense17false 5us-gaap_IncomeLossFromEquityMethodInvestmentsus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse8700087USD$falsefalsefalse2truefalsefalse105000105USD$falsefalsefalse3truefalsefalse162000162USD$falsefalsefalse4truefalsefalse214000214USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThis item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 9 -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 18 -Paragraph 6 -Subparagraph b -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=16385135&loc=d3e33749-111570 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 18 -Paragraph 19 -Subparagraph c -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.12) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 11 -Article 7 false2Equity in earnings of unconsolidated subsidiary18false 5us-gaap_NetIncomeLossAttributableToNoncontrollingInterestus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1falsefalsefalse00falsefalsefalse2truefalsefalse-130000-130USD$falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of Net Income (Loss) attributable to noncontrolling interest.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph a -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 1A -URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph c(1) -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4J -URI http://asc.fasb.org/extlink&oid=18733213&loc=SL4591551-111686 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph A1, A4, A5 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false2Net income attributable to noncontrolling interest19false 5us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse1656300016563USD$falsefalsefalse2truefalsefalse78410007841USD$falsefalsefalse3truefalsefalse1967900019679USD$falsefalsefalse4truefalsefalse1363300013633USD$falsefalsefalsexbrli:monetaryItemTypemonetaryNet income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 11 -URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1377-109256 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 9 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. true2Net income attributable to Envision Healthcare Corporation20false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5false USDtruefalse$D2013Q2_OperatingSegmentsMemberhttp://www.sec.gov/CIK0001344154duration2013-04-01T00:00:002013-06-30T00:00:00falsefalseSegmentus-gaap_StatementBusinessSegmentsAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_OperatingSegmentsMemberus-gaap_StatementBusinessSegmentsAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0Segment21true 3us-gaap_SegmentReportingInformationLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Segment Information22false 4evh_RevenueHealthCareOrganizationevh_falsecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse899255000899255USD$falsefalsefalse2truefalsefalse801098000801098USD$falsefalsefalse3truefalsefalse17875790001787579USD$falsefalsefalse4truefalsefalse16073920001607392USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThe sum of revenues recognized during the period by the entity from providing services to in-patients, outpatients, residents in facilities owned or operated by the entity, from insurance premiums, or from goods provided or services performed. For financial reporting purposes, revenue is reflected net of provisions for contractual allowances (the amount needed to reduce the entity's gross billing rates to agreed-upon rates in contracts with third-party payers) and provisions for uncompensated care (the amount needed to reduce revenue for services provided to patients without insurance or other third-party payer coverage).No definition available.false2Net revenue23false 4evh_IncomeLossBeforeInterestTaxDepreciationAndAmortizationNetevh_falsecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse105956000105956USD$falsefalsefalse2truefalsefalse9633200096332USD$falsefalsefalse3truefalsefalse206955000206955USD$falsefalsefalse4truefalsefalse187896000187896USD$falsefalsefalsexbrli:monetaryItemTypemonetaryRepresents income or loss from continuing operations excluding equity in earnings of unconsolidated subsidiary, income tax expense, loss on early debt extinguishment, interest and other (expense) income, realized (loss) gain on investments, interest expense, stock-based compensation, related party management fees, restructuring charges, and depreciation and amortization expense used by chief operating decision maker to assess performance, measure liquidity and make decisions.No definition available.false2Adjusted EBITDA24true 4evh_ReconciliationOfAdjustedEBITDAToNetIncomeAbstractevh_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Reconciliation of Adjusted EBITDA to Net Income25false 5evh_IncomeLossBeforeInterestTaxDepreciationAndAmortizationNetevh_falsecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse105956000105956USD$falsefalsefalse2truefalsefalse9633200096332USD$falsefalsefalse3truefalsefalse206955000206955USD$falsefalsefalse4truefalsefalse187896000187896USD$falsefalsefalsexbrli:monetaryItemTypemonetaryRepresents income or loss from continuing operations excluding equity in earnings of unconsolidated subsidiary, income tax expense, loss on early debt extinguishment, interest and other (expense) income, realized (loss) gain on investments, interest expense, stock-based compensation, related party management fees, restructuring charges, and depreciation and amortization expense used by chief operating decision maker to assess performance, measure liquidity and make decisions.No definition available.false2Adjusted EBITDA26false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse9false USDtruefalse$D2013Q2_FacilityBasedPhysicianServicesMemberhttp://www.sec.gov/CIK0001344154duration2013-04-01T00:00:002013-06-30T00:00:00falsefalseFacility-based physician servicesus-gaap_StatementBusinessSegmentsAxisxbrldihttp://xbrl.org/2006/xbrldievh_FacilityBasedPhysicianServicesMemberus-gaap_StatementBusinessSegmentsAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0Facility-based physician services27true 3us-gaap_SegmentReportingInformationLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Segment Information28false 4evh_RevenueHealthCareOrganizationevh_falsecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse569117000569117USD$falsefalsefalse2truefalsefalse468852000468852USD$falsefalsefalse3truefalsefalse11240530001124053USD$falsefalsefalse4truefalsefalse917856000917856USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThe sum of revenues recognized during the period by the entity from providing services to in-patients, outpatients, residents in facilities owned or operated by the entity, from insurance premiums, or from goods provided or services performed. For financial reporting purposes, revenue is reflected net of provisions for contractual allowances (the amount needed to reduce the entity's gross billing rates to agreed-upon rates in contracts with third-party payers) and provisions for uncompensated care (the amount needed to reduce revenue for services provided to patients without insurance or other third-party payer coverage).No definition available.false2Net revenue29false 4evh_IncomeLossBeforeInterestTaxDepreciationAndAmortizationNetevh_falsecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse7057500070575USD$falsefalsefalse2truefalsefalse6376700063767USD$falsefalsefalse3truefalsefalse136735000136735USD$falsefalsefalse4truefalsefalse120481000120481USD$falsefalsefalsexbrli:monetaryItemTypemonetaryRepresents income or loss from continuing operations excluding equity in earnings of unconsolidated subsidiary, income tax expense, loss on early debt extinguishment, interest and other (expense) income, realized (loss) gain on investments, interest expense, stock-based compensation, related party management fees, restructuring charges, and depreciation and amortization expense used by chief operating decision maker to assess performance, measure liquidity and make decisions.No definition available.false2Adjusted EBITDA30true 4evh_ReconciliationOfAdjustedEBITDAToNetIncomeAbstractevh_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Reconciliation of Adjusted EBITDA to Net Income31false 5evh_IncomeLossBeforeInterestTaxDepreciationAndAmortizationNetevh_falsecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse7057500070575USD$falsefalsefalse2truefalsefalse6376700063767USD$falsefalsefalse3truefalsefalse136735000136735USD$falsefalsefalse4truefalsefalse120481000120481USD$falsefalsefalsexbrli:monetaryItemTypemonetaryRepresents income or loss from continuing operations excluding equity in earnings of unconsolidated subsidiary, income tax expense, loss on early debt extinguishment, interest and other (expense) income, realized (loss) gain on investments, interest expense, stock-based compensation, related party management fees, restructuring charges, and depreciation and amortization expense used by chief operating decision maker to assess performance, measure liquidity and make decisions.No definition available.false2Adjusted EBITDA32false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse13false USDtruefalse$D2013Q2_MedicalTransportationServicesMemberhttp://www.sec.gov/CIK0001344154duration2013-04-01T00:00:002013-06-30T00:00:00falsefalseMedical transportation servicesus-gaap_StatementBusinessSegmentsAxisxbrldihttp://xbrl.org/2006/xbrldievh_MedicalTransportationServicesMemberus-gaap_StatementBusinessSegmentsAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0Medical transportation services33true 3us-gaap_SegmentReportingInformationLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Segment Information34false 4evh_RevenueHealthCareOrganizationevh_falsecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse330138000330138USD$falsefalsefalse2truefalsefalse332246000332246USD$falsefalsefalse3truefalsefalse663526000663526USD$falsefalsefalse4truefalsefalse689536000689536USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThe sum of revenues recognized during the period by the entity from providing services to in-patients, outpatients, residents in facilities owned or operated by the entity, from insurance premiums, or from goods provided or services performed. For financial reporting purposes, revenue is reflected net of provisions for contractual allowances (the amount needed to reduce the entity's gross billing rates to agreed-upon rates in contracts with third-party payers) and provisions for uncompensated care (the amount needed to reduce revenue for services provided to patients without insurance or other third-party payer coverage).No definition available.false2Net revenue35false 4evh_IncomeLossBeforeInterestTaxDepreciationAndAmortizationNetevh_falsecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse3538100035381USD$falsefalsefalse2truefalsefalse3256500032565USD$falsefalsefalse3truefalsefalse7022000070220USD$falsefalsefalse4truefalsefalse6741500067415USD$falsefalsefalsexbrli:monetaryItemTypemonetaryRepresents income or loss from continuing operations excluding equity in earnings of unconsolidated subsidiary, income tax expense, loss on early debt extinguishment, interest and other (expense) income, realized (loss) gain on investments, interest expense, stock-based compensation, related party management fees, restructuring charges, and depreciation and amortization expense used by chief operating decision maker to assess performance, measure liquidity and make decisions.No definition available.false2Adjusted EBITDA36true 4evh_ReconciliationOfAdjustedEBITDAToNetIncomeAbstractevh_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Reconciliation of Adjusted EBITDA to Net Income37false 5evh_IncomeLossBeforeInterestTaxDepreciationAndAmortizationNetevh_falsecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse3538100035381USD$falsetruefalse2truefalsefalse3256500032565USD$falsetruefalse3truefalsefalse7022000070220USD$falsetruefalse4truefalsefalse6741500067415USD$falsetruefalsexbrli:monetaryItemTypemonetaryRepresents income or loss from continuing operations excluding equity in earnings of unconsolidated subsidiary, income tax expense, loss on early debt extinguishment, interest and other (expense) income, realized (loss) gain on investments, interest expense, stock-based compensation, related party management fees, restructuring charges, and depreciation and amortization expense used by chief operating decision maker to assess performance, measure liquidity and make decisions.No definition available.false2Adjusted EBITDAfalseSegment Information (Details) (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.envisionhealthcare.net/role/DisclosureSegmentInformationDetails437